Stock ADXS AYALA PHARMACEUTICALS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Consensus Ayala Pharmaceuticals, Inc.

Equities

ADXS

US0076244062

Market Closed - OTC Markets
Other stock markets
 10:03:48 03/05/2024 pm IST 		5-day change 1st Jan Change
0.555 USD +4.62% Intraday chart for Ayala Pharmaceuticals, Inc. 0.00% -16.79%
16/04 Ayala Pharmaceuticals, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
16/04 Ayala Pharmaceuticals, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 CI

Evolution of the average Target Price on Ayala Pharmaceuticals, Inc.

Price target over the last 5 years

History of analyst recommendation changes

705216b41a24ca4f8356922c014b.e3CO6WaQOBV4izk6eGN7J1FYxuBZkXwJ4lxlFBH0qJ0.Vjz0iCelQFdO3FxPOyhDaGYWiLkv0w1tuAYCYnuN4MVWGLeBD_pTWhnJdA~0b3cc97060425a7fe021c66528151354

Analyst Recommendations on Ayala Pharmaceuticals, Inc.

North American Morning Briefing : Stocks Futures Steady on Rates Optimism DJ
North American Morning Briefing : Apple's China Conflict, Rate Hike Fears Continue to Weigh DJ
ADVAXIS : Alliance Global Adjusts Advaxis' Price Target to $2.25 From $5, Maintains Buy Rating MT
Advaxis Announces Updated Data at ASCO from a Phase 2 Study of AXAL in Advanced Cervical Cancer Showing Promising Survival Rates Consistent with Earlier Reports CI
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
1
Last Close Price
0.555
Average target price
-

Consensus detail

Consensus revision (last 18 months)

Analysts covering Ayala Pharmaceuticals, Inc.

Alliance Global Partners

Chiffre d''affaires - Rate of surprise

Company calendar
  1. Stock Market
  2. Equities
  3. ADXS Stock
  4. Consensus Ayala Pharmaceuticals, Inc.